SLC26A3 and adenocarcinoma: The down expression of five genes (SLC26A3, GUCA2A, CLCA4, CLCA1, and AQP8) was significantly associated with poor overall survival in colorectal cancer adenocarcinoma patients, and patients with lower expression levels of CLCA1 had poorer disease-free survival rates.